Announcement of the Establishment of Carenet Clinical Research Operations, Inc. (Abbreviation: CCRO)

Carenet Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director and President: Katsuhiro Fujii; hereinafter "the Company") hereby announces that its consolidated subsidiaries, Clayce Corporation (hereinafter "Clayce") and Satt Corporation (hereinafter "Satt"), completed an absorption-type merger (hereinafter "this Merger") on April 1, 2026, with Clayce as the surviving company and Satt as the dissolving company.

Furthermore, we are pleased to announce that on the same date, the surviving company, Clayce, changed its trade name to "Carenet Clinical Research Operations, Inc." (abbreviation: CCRO). We will promote advanced CRO services, covering everything from clinical development to clinical research, by maximizing the expertise cultivated by both companies and Carenet's physician member and media platforms.

1. Background and Purpose of Organizational Restructuring

Our group is committed to realizing better healthcare by providing high-quality information and services to healthcare professionals and pharmaceutical companies, with a focus on "Medicine x IT." Amidst the accelerating digitalization of the pharmaceutical industry and changes in the environment surrounding clinical development and clinical research, we decided to proceed with this merger based on a policy of integrating management resources within the group to establish a more agile and robust support system.

By integrating the strengths of Clayce in clinical development and Satt's achievements in clinical research, we aim to provide more value-added solutions to pharmaceutical companies and medical institutions.

2. Overview of the Integrated New Company

【Trade Name】 Carenet Clinical Research Operations, Inc. (Abbreviation: CCRO)

【Location】 Capital Akasaka Building 6F, 1-7-19 Akasaka, Minato-ku, Tokyo

【Representative】 Representative Director: Omito Kawasaki

【Capital】 15 million yen

【Business Activities】

・Contract research organization services and temporary staffing for clinical development operations, consulting on planning and execution of clinical development (domestic clinical trials)

・Contract research organization services for clinical research operations, consulting on planning and execution of clinical research

・Subject recruitment support

【Licenses/Registrations】

・Worker Dispatch Undertaking License Number: 派13-306875

・Paid Employment Placement Business License Number: 13-ユ309033

【Corporate Site】　https://ccro.co.jp/

3. Response to Business Partners

Accompanying this merger, there will be no changes to existing contracts, services provided, or contact points for our business partners. While building upon our established trusted relationships, we will strive to further improve the quality of our services under the new structure.

4. Future Outlook

Through the new company "CCRO," we will promote the integrated and efficient development of solutions in both clinical development and clinical research. The entire group will continue to respond flexibly to changes in the environment surrounding pharmaceutical development and contribute to the realization of better medical care.

We kindly ask for your continued guidance and encouragement.

◆ About Carenet

The Carenet Group operates with the purpose of "Supporting healthcare professionals and moving the future of medicine with knowledge, passion, and action," building its business on "CareNet.com" (https://www.carenet.com/), which has 240,000 physician members. We widely provide specialized services in the medical and pharmaceutical fields, ranging from medical human resources, education, and management to new drug development, clinical trials, and dissemination support. For an overview of Carenet Co., Ltd., please refer to https://carenet.co.jp/. Recruitment information can be viewed at https://carenet.co.jp/recruit/.